Research to Advance Vaccine Safety Program

by: Iola Bonggay

The Centers for Disease Control and Prevention, more commonly referred to as CDC, is a United States federal agency operating within the Department of Health and Human Services that is primarily responsible for safeguarding public health and safety by way of providing essential health-related information and forming partnerships with state health department and several other organizations.

The programs and activities that are launched by the CDC are in accordance to their agency mission, which is to "Collaborate to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats."

In keeping with this mission, the Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

The discovery of vaccines is considered as a great medical breakthrough as it has contributed to the successful eradication of naturally occurred smallpox, and a substantial reduction of certain disease conditions that are caused by measles, mumps, influenza, hepatitis, diphtheria, and several other infections.

The Research to Advance Vaccine Safety Program aims to boost this medical breakthrough by funding scientific studies that address potentially relevant vaccine safety concerns such as:

1) A human being's immunological and physiological responses to vaccine and vaccine components.

  (continued...)

Research to Advance Vaccine Safety Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on grants for youth programs and home improvement grants.

Additional Resources

category - Health Grants

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening
Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program enables eligible health care institutions to solicit funds by establishing project proposals that would greatly improve the number of infants receiving appropriate and timely follow-ups through the utilization of patient-centered interventions.

---